Skip to main content
. 2016 Mar 2;7(16):21763–21774. doi: 10.18632/oncotarget.7845

Table 1. IHC Results (+ slightly positive, ++ moderately positive, +++ strongly positive, - negative, NT no tumor).

CCND1 CDK4 c-MYC CTLA-4 CTNNB1 EGFR EPCAM ERBB2 IMP3 KIT INI-1 MKI67 MDM2 MET p40 TP53 PD-L1 SOX2
AFX
+ 2 1 1 4×3-5%
++ 1 1 5 2
+++ 3 1×20-25% 2
- 1 3 5 5 5 4 5 5 3 5 5 5 5 1 5 5
NT
PDS 1×3-5%
+ 3 1 3 4×10-15% 1
++ 4 6 1×20-25% 3
+++ 2 1 1
- 1 5 3 2 6 5 6 6 1 6 6 6 4 2 6 6
NT 1 1 1 1 1